Expanded GTM services aim to ensure members receive tests at the optimal times while cutting down on testing misuse.

The two organizations will produce educational materials about the medicine and its importance for people living with type 1 ...

PharmaScroll announced a new generative AI chatbot called Self-Serve AI. 1 The company describes it as a research and ...

Cary Claiborne, CEO, Adial Pharmaceuticals, discusses AD04’s development timeline and next steps towards approval for alcohol use disorder.

Data from a Phase Ia single ascending dose study found that ASC30 demonstrated dose-proportional pharmacokinetics, a ...

CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).